A detailed history of Jacobs Levy Equity Management, Inc transactions in Biote Corp. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 272,377 shares of BTMD stock, worth $1.62 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
272,377
Previous 218,075 24.9%
Holding current value
$1.62 Million
Previous $1.63 Million 6.75%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.33 - $8.36 $289,429 - $453,964
54,302 Added 24.9%
272,377 $1.52 Million
Q2 2024

Aug 14, 2024

BUY
$5.44 - $7.47 $1.19 Million - $1.63 Million
218,075 New
218,075 $1.63 Million

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $45.1M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.